Ledger.Open graph →
SEC Form D · Amendment · filed October 29, 2009

Virdante Pharmaceuticals, Inc

Offering
$47.8M
Sold
$30.1M
Exemption
—
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (12)

John Ripple · Cambridge, MAExec · DirectorEric Aguiar · Cambridge, MADirectorMichael Steinmetz · Cambridge, MADirectorL. P. Gage · Cambridge, MADirectorGail Wasserman · Cambridge, MADirectorAnders Hove · Cambridge, MADirectorJohn W. Vander Vort · BOSTON, MAExec · DirectorDavid M. Sherman · New York, NYDirectorT. R. Burke · New York, NYDirectorDavid G. Nasaw · New York, NYDirectorMartin Taylor · San Francisco, CADirectorChristian B. Sowul · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗